Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #37     Novo Nordisk and AB Science disclose preliminary positive results in the treatment of Alzheimer’s disease     Over the last months we have mainly published on COVID-19 treatments and outcomes. Earlier this week important and unexpected results were […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com        SPECIAL REPORT #36     US FDA grants EUA to Pfizer/BioNTech COVID-19 vaccine     The second part of the week was also been highly intense on the COVID-19 front.   Just 24 hours after the Vaccine and Related Biological Products Advisory […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com        SPECIAL REPORT #35   COVID-19 News early this week     We are going to have another busy week on the COVID-19 news front.   It started Tuesday December 8, with what U.K. officials dubbed “V-Day” whith the roll out of BioNTech/Pfizer […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com    SPECIAL REPORT #34   U.K. grants Pfizer/BioNTech Emergency Use for their COVID-19 Vaccine.       In our previous report, we had wondered if the U.K. would approve Pfizer/BioNTech’s BNT162b, their COVID-19 vaccine ahead of the European Union, but we had not anticipated that […]